ReviewCancers2019

Radioiodine-Refractory Thyroid Cancer: Molecular Basis of Redifferentiation Therapies, Management, and Novel Therapies.

Mohamed Aashiq et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.